Omer Butt

Omer Butt is an experienced regulatory affairs professional currently serving as Vice President of Regulatory Affairs at CytoImmune Therapeutics since March 2022. Prior experience includes roles as Senior Director and Director of CMC Regulatory Affairs at Athersys, where responsibilities encompassed regulatory activities for Allo Cell Therapy Programs and pivotal trials across multiple regions. Omer’s career also features significant positions at prominent companies such as Sanofi, Shire Pharmaceuticals, and Biogen Idec, focusing on regulatory strategy and CMC leadership for various pharmaceutical projects. Omer Butt's regulatory expertise is bolstered by a foundational role at the FDA, coupled with extensive regulatory review experience and inspection responsibilities. Omer Butt holds a PhD in Biomedical Engineering from The Ohio State University, complemented by a Master's degree and Bachelor's degree from the same institution.